ETF Managers Group’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$75.2K Buy
+12,961
New +$112K ﹤0.01% 651
2022
Q4
Sell
-11,770
Closed -$37K 705
2022
Q3
$37K Sell
11,770
-781
-6% -$4.88K ﹤0.01% 675
2022
Q2
$88K Buy
12,551
+708
+6% +$5.52K ﹤0.01% 682
2022
Q1
$63K Buy
11,843
+44
+0.4% +$692 ﹤0.01% 651
2021
Q4
$272K Sell
11,799
-2,562
-18% -$66.2K 0.01% 597
2021
Q3
$421K Buy
+14,361
New +$487K 0.01% 564

Other funds holding ICVX

ETF Managers Group's ICVX Position: Q1 2023 in Review

ETF Managers Group opened a new position in Icosavax, Inc. Common Stock (ICVX) in Q1 2023: 12,961 shares worth $75.2K. The stake represents ﹤0.01% of the portfolio and ranks #651 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in ICVX as recently as Q3 2022.

ETF Managers Group first reported a position in ICVX in Q3 2021 and has held it in 6 quarters since. The position peaked at $421K in Q3 2021. 66 funds tracked by Wall St. Rank hold ICVX as of Q1 2023.

  • ETF Managers Group held 12,961 shares of Icosavax, Inc. Common Stock worth $75.2K as of Q1 2023.
  • Icosavax, Inc. Common Stock was a new ETF Managers Group position in Q1 2023.
  • Icosavax, Inc. Common Stock made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #651 holding.
  • ETF Managers Group first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and has held it in 6 quarters since.
  • ETF Managers Group's Icosavax, Inc. Common Stock position peaked at $421K in Q3 2021.
  • 66 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.